title: Undertested and Overpriced: Japan Issues First Conditional Approval of Stem Cell Product.
authors.affiliation: University of Alberta, Edmonton, AB T6G 2R3, Canada.
authors.forename: Christopher
authors.initials: C
authors.lastname: McCabe
authors.affiliation: RIKEN Center for Developmental Biology, 2-2-3 Minatojima-minamimachi, Chuou-ku, Kobe 650-0047, Japan; Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: sipp@cdb.riken.jp.
authors.forename: Douglas
authors.initials: D
authors.lastname: Sipp
mesh_terms: D064987:Cell- and Tissue-Based Therapy / Q000191:economics* / Q000592:standards*; D006801:Humans; D007564:Japan; D062307:Medical Device Legislation; D044968:Regenerative Medicine; D013234:Stem Cells